Author

Sapna Pradyuman Patel

The University of Texas MD Anderson Cancer CenterORCID 0000-0003-1339-1517Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Beteleham Yacob· 1 shared Bo WeiiD· 1 shared Chandrani ChattopadhyayiD· 1 shared Eduardo DávilaiD· 1 shared Elizabeth Ann GrimmiD· 1 shared Elizabeth M. BurtoniD· 1 shared Fatima Sharif KhaniD· 1 shared Iqbal MahmudiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Beteleham Yacob

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyMolecular Cancer TherapeuticsPeer-reviewedJul 13, 2026

Decitabine reverses innate immune gene suppression in rare melanomas

Morgan L. MacBeth, Stacey M. Bagby, Jessica S.W. Borgers…·Kasey L. Couts

This study identifies immune evasion mechanisms in rare melanomas and shows that decitabine reactivates innate immune pathways, improving immune responsiveness.

3 citationstop 3%

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyBritish Journal of CancerPeer-reviewedOct 11, 2024

Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanoma

Chandrani Chattopadhyay, Jason Roszik, Rajat Bhattacharya…·Elizabeth Ann Grimm

The paper tests imipridones in a mouse model of uveal melanoma, finding they reduce tumor growth and improve survival by targeting oxidative phosphorylation.

14 citationstop 4%

mousebulk RNA-seq

𝕏 PostBluesky